This blend combines CJC-1295 (no DAC), a modified growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (no DAC) produces sustained, dose-dependent GH and IGF-1 increases, while Ipamorelin selectively stimulates GH release without raising ACTH or cortisol.
This blend combines CJC-1295 (no DAC), a modified growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (no DAC) produces sustained, dose-dependent GH and IGF-1 increases, while Ipamorelin selectively stimulates GH release without raising ACTH or cortisol.